Antimicrobial Agents Practice Questions

Q: Which drug is known to cause visual disturbances?

Ethambutol. **Explanation:** **Ethambutol** is a bacteriostatic antitubercular drug that inhibits the enzyme **arabinosyl transferase**, thereby interfering with the synthesis of the mycobacterial cell wall. **Why Ethambutol is the correct answer:** The most characteristic and dose-dependent side effect of Ethambutol is **Retrobulbar Neuritis**. This manifests as: * **Decreased visual acuity.** * **Red-green color blindness** (often the earliest sign). * Central scotomas. These effects are usually reversible upon discontinuation of the drug, but baseline and periodic ophthalmological examinations are mandatory during treatment. **Analysis of Incorrect Options:** * **Pyrazinamide (A):** Primarily known for causing **hyperuricemia** (leading to gout) and hepatotoxicity. It does not typically affect vision. * **Rifampin (B):** Its hallmark side effect is the **orange-red discoloration** of body fluids (urine, sweat, tears). While it can cause "Flu-like syndrome," it is not associated with optic neuritis. * **PAS (Para-aminosalicylic acid) (D):** A second-line agent mainly associated with severe gastrointestinal intolerance and occasional hypothyroidism or sodium overload. **High-Yield Clinical Pearls for NEET-PG:** 1. **Safe in Pregnancy:** Ethambutol is generally considered the safest first-line ATT drug during pregnancy. 2. **Renal Adjustment:** It is primarily excreted by the kidneys; hence, the dose must be adjusted in patients with renal failure. 3. **Pediatric Caution:** It is usually avoided in children young enough that visual acuity and color vision cannot be accurately monitored (typically <6 years). 4. **Mnemonic:** **E**thambutol for **E**ye (Optic neuritis).

Q: Which drug is known to cause hemolysis in individuals with G6PD deficiency?

Primaquine. **Explanation:** **Primaquine** is the correct answer because it is a potent oxidizing agent. In individuals with **Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency**, erythrocytes cannot generate sufficient **NADPH**, which is essential for maintaining a pool of reduced glutathione. Without reduced glutathione, the red blood cells cannot neutralize the oxidative stress caused by Primaquine, leading to the denaturation of hemoglobin (forming **Heinz bodies**) and subsequent hemolysis. **Analysis of Options:** * **Primaquine (Correct):** It is the classic example of a drug causing oxidative hemolysis in G6PD deficiency. It is used for the radical cure of *P. vivax* and *P. ovale* to kill latent tissue hypnozoites. * **Chloroquine:** Generally considered safe in G6PD-deficient patients at standard doses. It acts on the erythrocytic stage by inhibiting heme polymerase. * **Quinine:** While it can rarely cause immune-mediated thrombocytopenia or "Blackwater fever," it is not typically associated with G6PD-induced hemolysis. * **Halofantrine:** Its primary significant adverse effect is **QT interval prolongation**; it does not pose a specific risk for G6PD-related hemolysis. **High-Yield Clinical Pearls for NEET-PG:** * **Mandatory Screening:** Always screen for G6PD levels before prescribing Primaquine or **Tafenoquine**. * **Other G6PD Triggers:** Sulfonamides, Dapsone, Nitrofurantoin, and Fava beans. * **Morphology:** Look for **"Bite cells"** (degmacytes) and **Heinz bodies** on a peripheral smear during a hemolytic episode. * **Contraindication:** Primaquine is strictly contraindicated in **pregnancy** because the G6PD status of the fetus cannot be determined.

Q: Aerosolized ribavirin is used in the treatment of bronchiolitis with which of the following pathogens?

Respiratory Syncytial Virus (RSV). **Explanation:** **Correct Answer: A. Respiratory Syncytial Virus (RSV)** Ribavirin is a synthetic guanosine analogue that interferes with the replication of viral RNA [2]. It inhibits the capping of viral mRNA and the enzyme RNA-dependent RNA polymerase. Its **aerosolized form** (delivered via a Small Particle Aerosol Generator - SPAG) is specifically indicated for severe lower respiratory tract infections, such as **bronchiolitis and pneumonia**, caused by **Respiratory Syncytial Virus (RSV)**, particularly in hospitalized infants or immunocompromised patients [1]. **Why the other options are incorrect:** * **B, C, and D (H. influenzae, S. pneumoniae, S. pyogenes):** These are all **bacterial pathogens**. Ribavirin is an antiviral agent and has no clinical activity against bacteria. Bronchiolitis is primarily a viral syndrome; bacterial infections like these typically cause pneumonia, epiglottitis, or pharyngitis and require treatment with appropriate antibiotics (e.g., Ceftriaxone or Amoxicillin). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Ribavirin is phosphorylated to its active triphosphate form by host cell enzymes. It induces "lethal mutagenesis" in RNA viruses [2]. * **Other Uses:** Oral ribavirin is used in combination with Interferon-alpha for **Chronic Hepatitis C** and is the drug of choice for **Lassa fever** [1]. * **Teratogenicity:** Ribavirin is highly teratogenic (Category X) [1]. Pregnancy must be avoided for 6 months after treatment in both female patients and female partners of male patients. * **Side Effects:** The most common side effect of systemic ribavirin is **dose-dependent hemolytic anemia**. Aerosolized use can cause conjunctival irritation or worsening of respiratory status [3].

Q: Even in large dosages used in malaria, quinine does not cause toxicity because why?

Elevated plasma alpha acid glycoprotein. ### Explanation The correct answer is **B. Elevated plasma alpha acid glycoprotein.** **Mechanism and Concept:** Quinine is a basic drug that primarily binds to **Alpha-1 Acid Glycoprotein (AAG)** in the plasma. In patients with acute malaria, AAG levels significantly increase because it is an "acute-phase reactant." This elevation leads to an increase in the protein-bound fraction of quinine, thereby **decreasing the free (unbound) fraction** of the drug in the plasma. Since only the free drug is pharmacologically active and capable of causing toxicity, the elevated AAG acts as a protective buffer, allowing patients to tolerate high dosages without experiencing severe side effects like cinchonism. **Why other options are incorrect:** * **A. It enters in fat cells:** Quinine is not highly lipophilic; it has a large volume of distribution but primarily binds to tissues like the liver, kidneys, and muscles, not specifically fat cells. * **C. Deposited in infected RBCs:** While quinine does concentrate in erythrocytes to exert its antimalarial effect, this sequestration is not the primary mechanism that prevents systemic toxicity. * **D. Excreted rapidly in urine:** Quinine is primarily metabolized by the liver (CYP3A4). Only a small fraction is excreted unchanged in the urine, and its half-life is actually prolonged in severe malaria. **High-Yield Clinical Pearls for NEET-PG:** * **Acidic drugs** (e.g., NSAIDs, Warfarin, Phenytoin) bind primarily to **Albumin**. * **Basic drugs** (e.g., Quinine, Lidocaine, Propranolol) bind primarily to **Alpha-1 Acid Glycoprotein**. * **Cinchonism:** The classic triad of quinine toxicity includes tinnitus, visual disturbances, and headache. * **Hypoglycemia:** A common side effect of quinine due to the stimulation of pancreatic beta cells to release insulin.

Q: Which antibiotic acts by interfering with the addition of new cell wall subunits (muramyl pentapeptides)?

Vancomycin. ### Explanation **Correct Option: C. Vancomycin** Vancomycin is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan precursor (muramyl pentapeptide). This binding creates a "steric hindrance" that prevents the **transglycosylase** enzyme from adding new subunits to the growing peptidoglycan chain. By interfering with the addition of these subunits, it halts the elongation of the cell wall. **Analysis of Incorrect Options:** * **A. Bacitracin:** Inhibits cell wall synthesis by interfering with the **dephosphorylation of the lipid carrier (bactoprenol)**, which transports peptidoglycan subunits across the cell membrane. It does not bind to the subunits themselves. * **B. Penicillins:** These are Beta-lactams that inhibit the **transpeptidase** enzyme (Penicillin Binding Proteins). They prevent the **cross-linking** of peptidoglycan chains rather than the addition of new subunits. * **C. Mupirocin:** This is a protein synthesis inhibitor. It acts by binding to bacterial **isoleucyl-tRNA synthetase**, preventing the incorporation of isoleucine into nascent proteins. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** The most common mechanism for Vancomycin resistance (e.g., VRSA/VRE) is the alteration of the binding site from **D-Ala-D-Ala to D-Ala-D-Lac**. * **Red Man Syndrome:** A common infusion-related reaction caused by direct histamine release (not a true IgE-mediated allergy). It is managed by slowing the infusion rate. * **Spectrum:** Vancomycin is active only against **Gram-positive** bacteria (it is too large to pass through the porins of Gram-negative outer membranes). * **Drug of Choice:** It remains the gold standard for **MRSA** (Methicillin-resistant *Staphylococcus aureus*).

Q: Ritonavir boosting is not recommended with which of the following protease inhibitors of HIV?

Nelfinavir. **Explanation:** The concept of **"Ritonavir Boosting"** relies on the ability of Ritonavir to act as a potent inhibitor of the **CYP3A4 enzyme**. By inhibiting this enzyme, Ritonavir slows the metabolism of co-administered Protease Inhibitors (PIs), leading to higher plasma concentrations, a longer half-life, and reduced dosing frequency. **Why Nelfinavir is the Correct Answer:** Nelfinavir is the only Protease Inhibitor that is **not** boosted by Ritonavir. Unlike other PIs, Nelfinavir is primarily metabolized by **CYP2C19** (and to a lesser extent by CYP3A4 and CYP2C9). Furthermore, Nelfinavir’s active metabolite (M8) is also potent. Because its primary metabolic pathway is not CYP3A4-dependent, adding Ritonavir does not significantly increase its plasma levels to a clinically beneficial degree. **Analysis of Incorrect Options:** * **Darunavir & Lopinavir:** These are "second-generation" PIs that are almost always administered with Ritonavir. In fact, Lopinavir is only available as a fixed-dose combination with Ritonavir (Kaletra) because its bioavailability is too poor otherwise. * **Saquinavir:** This was the first PI developed. It has very low oral bioavailability, which is significantly improved (boosted) when combined with Ritonavir. **High-Yield Clinical Pearls for NEET-PG:** * **Lopinavir/Ritonavir:** The "Gold Standard" for boosted PI therapy, often used in second-line ART regimens. * **Adverse Effects:** PIs are classically associated with **Lipodystrophy** (buffalo hump), **Hyperlipidemia**, and **Insulin Resistance**. * **Nelfinavir Specifics:** It is frequently associated with **diarrhea** as a major side effect. * **Atazanavir:** Another PI that requires boosting; it is unique for causing unconjugated hyperbilirubinemia (benign jaundice).

Q: What is the drug of choice for Falciparum Malaria?

Artemisinin-based Combination Therapy (ACT). **Explanation:** The management of malaria is a high-yield topic for NEET-PG, focusing on drug resistance patterns and current WHO/National guidelines. **Why ACT is the Correct Answer:** **Artemisinin-based Combination Therapy (ACT)** is currently the global drug of choice for **uncomplicated *Plasmodium falciparum* malaria**. The rationale behind using a combination (e.g., Artesunate + Sulfadoxine-Pyrimethamine or Artemether + Lumefantrine) is twofold: 1. **Rapid Clearance:** Artemisinins are the fastest-acting schizontocides, reducing the parasite biomass rapidly. 2. **Resistance Prevention:** The longer-acting partner drug eliminates residual parasites, preventing the development of resistance to artemisinin. **Analysis of Incorrect Options:** * **A. Chloroquine:** While it remains the drug of choice for *P. vivax*, it is no longer used for *P. falciparum* due to widespread **high-level resistance** (mutations in the *pfcrt* gene). * **B. Mefloquine:** Used primarily for prophylaxis in travelers or as a component of certain ACTs (Artesunate + Mefloquine), but it is not the first-line monotherapy due to neuropsychiatric side effects. * **D. Proguanil:** Usually used in combination with Atovaquone (Malarone) for prophylaxis or treatment in specific regions, but it is not the standard first-line recommendation for *falciparum* in endemic areas like India. **Clinical Pearls for NEET-PG:** * **Severe/Complicated Malaria:** The drug of choice is **Intravenous (IV) Artesunate**. * **Pregnancy:** ACT is now recommended for *falciparum* malaria in **all trimesters** (including the first). * **Gametes:** Artemisinins have gametocytocidal action against *P. falciparum*, helping reduce transmission. * **India Specific:** In India, the preferred ACT is **Artesunate + Sulfadoxine-Pyrimethamine (AS+SP)**, except in North-Eastern states where **Artemether + Lumefantrine** is used due to SP resistance.

Q: Which anti-malarial drugs are effective in the pre-erythrocytic phase in the liver?

Proguanil. **Explanation:** Anti-malarial drugs are classified based on the stage of the *Plasmodium* life cycle they target. The **pre-erythrocytic (exo-erythrocytic) phase** occurs in the liver immediately after a mosquito bite, before the parasites enter the bloodstream. **1. Why Proguanil is Correct:** Proguanil (and its active metabolite cycloguanil) acts as a **causal prophylactic** agent. It inhibits the enzyme dihydrofolate reductase (DHFR), disrupting DNA synthesis in the primary liver stages of both *P. falciparum* and *P. vivax*. This prevents the infection from ever reaching the red blood cells. It is often used in combination with Atovaquone (Malarone) for this purpose. **2. Why the Incorrect Options are Wrong:** * **Chloroquine:** It is a potent **blood schizonticide**. It acts by inhibiting heme polymerase in the erythrocytic stage but has no activity against liver stages. * **Pyrimethamine:** While it also inhibits DHFR, it is primarily effective against the erythrocytic stages and is used as a **slow-acting blood schizonticide** (usually combined with Sulfadoxine). It is not typically used for causal prophylaxis. * **Quinine:** An alkaloid that acts as a rapid **blood schizonticide**. It is used for severe malaria but lacks activity against any hepatic stages. **High-Yield NEET-PG Pearls:** * **Causal Prophylactics (Liver stage):** Proguanil, Primaquine, and Pyrimethamine (weakly). * **Radical Cure (Hypnozoites):** Primaquine and Tafenoquine are the only drugs that kill dormant liver stages (*P. vivax/ovale*). * **Drug of Choice for Pregnancy:** Chloroquine (if sensitive); Quinine is safe for severe malaria in all trimesters. * **Proguanil Side Effect:** Mouth ulcers (stomatitis) are a characteristic adverse effect.

Q: Which of the following antibiotics are safe to treat urinary tract infections in pregnancy?

Penicillins and Cephalosporins. ### Explanation **1. Why Penicillins and Cephalosporins are Correct:** In pregnancy, drug safety is categorized based on the potential risk to the fetus. **Penicillins** (e.g., Amoxicillin, Ampicillin) and **Cephalosporins** (e.g., Cephalexin, Ceftriaxone) are considered **Category B** drugs. They are the first-line agents for treating Urinary Tract Infections (UTIs) because they lack teratogenic potential and have a high therapeutic index. Their mechanism of action—inhibiting bacterial cell wall synthesis—targets a process absent in human cells, making them exceptionally safe for both the mother and the developing fetus. **2. Why Other Options are Incorrect:** * **Aminoglycosides (Options A & B):** These are contraindicated (Category D) as they can cause **fetal ototoxicity** (damage to the 8th cranial nerve) and potential nephrotoxicity. * **Fluoroquinolones/Ciprofloxacin (Options B & D):** These are avoided in pregnancy because they have a high affinity for bone and cartilage, potentially leading to **arthropathy** and permanent cartilage damage in the fetus. * **Cotrimoxazole (Option D):** This is a combination of Sulfonamides and Trimethoprim. Trimethoprim is a **folate antagonist** (risk of neural tube defects in the 1st trimester), and Sulfonamides can displace bilirubin from albumin, leading to **kernicterus** in the newborn if used near term. **3. NEET-PG High-Yield Pearls:** * **Nitrofurantoin:** Safe in the 2nd trimester but contraindicated at term (38-42 weeks) due to the risk of **hemolytic anemia** in the newborn (due to immature G6PD enzymes). * **Fosfomycin:** A single-dose safe alternative for uncomplicated cystitis in pregnancy. * **Asymptomatic Bacteriuria:** In pregnancy, this **must** always be treated to prevent progression to pyelonephritis and preterm labor.

Question 1

Which drug is known to cause visual disturbances?

Accepted Answer

Ethambutol

Answer

Pyrazinamide

Answer

Rifampin

Answer

PAS

Question 2

Which drug is known to cause hemolysis in individuals with G6PD deficiency?

Accepted Answer

Primaquine

Answer

Chloroquine

Answer

Quinine

Answer

Halofantrine

Question 3

Aerosolized ribavirin is used in the treatment of bronchiolitis with which of the following pathogens?

Accepted Answer

Respiratory Syncytial Virus (RSV)

Answer

Haemophilus influenzae

Answer

Streptococcus pneumoniae

Answer

Streptococcus pyogenes

Question 4

A bedridden female patient has a catheter-related urinary tract infection caused by beta-lactamase producing Klebsiella pneumoniae. Which of the following drugs would you choose?

Accepted Answer

Beta-lactam and beta-lactamase inhibitors

Answer

Ampicillin

Answer

2nd generation cephalosporins

Answer

3rd generation cephalosporins

Question 5

Even in large dosages used in malaria, quinine does not cause toxicity because why?

Accepted Answer

Elevated plasma alpha acid glycoprotein

Answer

It enters in fat cells

Answer

Deposited in infected RBCs

Answer

Excreted rapidly in urine

Question 6

Which antibiotic acts by interfering with the addition of new cell wall subunits (muramyl pentapeptides)?

Accepted Answer

Vancomycin

Answer

Bacitracin

Answer

Penicillins

Answer

Mupirocin

Question 7

Ritonavir boosting is not recommended with which of the following protease inhibitors of HIV?

Accepted Answer

Nelfinavir

Answer

Darunavir

Answer

Saquinavir

Answer

Lopinavir

Question 8

What is the drug of choice for Falciparum Malaria?

Accepted Answer

Artemisinin-based Combination Therapy (ACT)

Answer

Chloroquine

Answer

Mefloquine

Answer

Proguanil

Question 9

Which anti-malarial drugs are effective in the pre-erythrocytic phase in the liver?

Accepted Answer

Proguanil

Answer

Chloroquine

Answer

Pyrimethamine

Answer

Quinine

Question 10

Which of the following antibiotics are safe to treat urinary tract infections in pregnancy?

Accepted Answer

Penicillins and Cephalosporins

Answer

Aminoglycosides and Penicillins

Answer

Aminoglycosides and Ciprofloxacin

Answer

Cotrimoxazole and Ciprofloxacin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?